Navigation Links
Gasification method turns forest residues to biofuel with less than a euro per liter
Date:7/3/2013

According to the new research results of the VTT Technical Research Centre of Finland, lignocellulosic biomass can be used in the production of high-quality biofuels for the price of less than one euro per litre. A new technology developed in Finland allows the transfer of more than half the energy of wood raw materials to the end-product. The technology is considered ready for the construction of a commercial-scale production plant in Europe.

VTT has assessed the techno-economics of the production of renewable liquid transportation fuels from forest residues. The case studies focused on the production of four biofuels using a method based on pressurised fluidised-bed gasification. The fuels studied were methanol, dimethyl ether (DME), Fischer-Tropsch liquids and synthetic gasoline.

The results show that the production of renewable biofuels from lignocellulosic biomass, mainly bark and forestry residues, could achieve an energy efficiency of 50%, depending on the end-product and process conditions. Should the thermal energy produced as a by-product be exploited for district heat or industrial steam, for example, the overall efficiency from biomass to saleable energy products could reach 74%.

Based on the case studies, the research scientists estimated that once commercialised the technology can be used to produce liquid transportation fuel at the cost of 58 /MWh. Converted into gasoline-equivalent price per litre, the estimated production cost would be 0.5.7 /litre. The price of renewable solutions would thus be on a level with the current pre-tax price of fossil transportation fuels, and cheaper than existing imported biofuels.

Each case study design was based on a BTL plant with 300 MW capacity, the equivalent of a large district heating power plant. A biorefinery of this size could produce liquid transportation fuel for about 150 000 cars. The EU has set a target of 10% renewable energy content for the transportation sector by 2020. For Finland, the target is 20%.

After long-term development work, the technical functionality of the production process was verified through extensive testing at VTT test rigs as well as industrial piloting in Finland and in the US. The technology is now ready for its first commercial-scale demonstration. However, the first wave of these ground-breaking production plants requires significant public venture capital investment, for which planning has consequently been initiated at both Finnish and EU level.

According to the research results, the best efficiency and lowest production costs were achieved in the production of biomethanol. The risks related to the commercialisation of the synthesis technology were also estimated to be lower with the biomethanol production plant compared to the other options.

Methanol is an alcohol fuel that can be used in modern cars at maximum 3 vol-% content in combination with petrol or, as with ethanol, in high concentrations in FlexFuel cars designed for this purpose. Methanol can also be further converted to synthetic gasoline or used as renewable raw material in the manufacture of various chemicals and biomaterials.


'/>"/>

Contact: Esa Kurkela
esa.kurkela@vtt.fi
358-207-225-596
VTT Technical Research Centre of Finland
Source:Eurekalert

Related biology news :

1. Gasification method turns forest residues to biofuel with less than a euro per litre
2. Bioliq pilot plant: Successful operation of high-pressure entrained flow gasification
3. Too green to be true? Researchers develop highly effective method for converting CO2 into methanol
4. Testing method promising for spinal cord injuries, multiple sclerosis
5. Researchers develop a faster method to identify Salmonella strains
6. Research examines new methods for managing digestive health
7. New X-ray method shows how frog embryos could help thwart disease
8. Researchers reveal new more precise method of performing electroconvulsive therapy
9. Resistant starch content of potatoes varies significantly by preparation and service method
10. New research projects to enhance bioinformatics and computational biology tools and methodologies
11. Material screening method allows more precise control over stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):
(Date:9/19/2017)... ... September 19, 2017 , ... Band-LOK, LLC, ... announced today that two new patents have been allowed by the USPTO on ... Band-LOK, said, “We continue to explore additional clinically-relevant designs for both the implants ...
(Date:9/18/2017)... , a growing leader in Electronic Trial Master file solutions ... research organization, Multidisciplinary Association for Psychedelic Studies (MAPS). ... MAPS Public Benefit Corporation selects ... ... for the treatment of Posttraumatic Stress Disorder (PTSD). MAPS also reached ...
(Date:9/15/2017)... San Diego, CA (PRWEB) , ... September 15, ... ... manufacturer Grolltex, has recently closed what it calls an ‘Internal Seed B’ round ... of the company’s stock and was completed using a ‘SAFE’ documentation structure at ...
(Date:9/14/2017)... Frederick, Maryland (PRWEB) , ... ... ... today, proudly announces the launch of its CliniControl™ (CC) product portfolio, clinically-relevant ... manufacturing, accelerating clinical translation of human Mesenchymal Stem/Stromal Cell (hMSC)-based therapies. The ...
Breaking Biology Technology: